V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210320 | 20078282 | 1.62 | 78 | Curative (C) | 2016-09-14 | 2016-10-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101452808 |
| 20210322 | 20078283 | 1.74 | 61.8 | Neo-adjuvant (N) | 2020-03-07 | 2020-03-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100306081 |
| 20210325 | 20078284 | 1.52 | 76.5 | Palliative (P) | 2019-10-13 | 2019-10-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101786959 |
| 20210326 | 20078285 | 1.63 | 61.5 | Neo-adjuvant (N) | 2018-04-23 | 2018-05-08 | Capecitabine (21days) + Carboplatin | N | N | CAPECITABINE + CARBOPLATIN | 100037464 |
| 20210331 | 20078286 | 1.7 | 49.2 | Curative (C) | 2018-10-06 | 2018-10-17 | Cisplatin +Fluorouracil (3 wk) | null | Y | CISPLATIN + FLUOROURACIL | 100601670 |
| 20210333 | 20078287 | 1.78 | 117.3 | null | 2020-01-18 | 2020-01-18 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100406979 |
| 20210334 | 20078288 | 1.67 | 39.7 | Curative (C) | 2019-02-20 | 2019-02-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101391313 |
| 20210335 | 20078289 | 1.67 | 81.6 | Curative (C) | null | 2019-02-25 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100118884 |
| 20210338 | 20078290 | 0 | 0 | Neo-adjuvant (N) | 2018-04-09 | 2018-04-27 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100021543 |
| 20210345 | 20078291 | 1.72 | 82.5 | Curative (C) | null | 2018-01-18 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101720263 |
| 20210348 | 20078292 | 1.91 | 93.1 | Neo-adjuvant (N) | 2017-07-13 | 2017-07-17 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101018403 |
| 20210350 | 20078293 | 1.7 | 79.6 | 03 | 2017-07-23 | 2017-07-25 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101112531 |
| 20210355 | 20078294 | 1.48 | 90.5 | Palliative (P) | 2019-04-13 | 2019-04-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101347591 |
| 20210362 | 20078295 | 1.56 | 96.1 | Neo-adjuvant (N) | 2019-04-27 | 2019-05-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100832695 |
| 20210363 | 20078296 | 1.76 | 60.5 | 03 | 2018-10-20 | 2018-11-05 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101324500 |
| 20210367 | 20078297 | 1.66 | 113.6 | Palliative (P) | 2017-08-06 | 2017-08-15 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100319050 |
| 20210368 | 20078298 | 1.76 | 62.6 | Curative (C) | 2018-10-12 | 2018-10-21 | CISPLATIN + FLUOROURACIL | 02 | y | CISPLATIN + FLUOROURACIL | 101177350 |
| 20210371 | 20078299 | 1.68 | 65 | Palliative (P) | 2019-06-02 | 2019-06-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100043404 |
| 20210374 | 20078300 | 1.65 | 127 | Palliative (P) | 2017-10-27 | 2017-11-02 | Cisplatin + Fluorouracil + RT 5day | N | null | CISPLATIN + FLUOROURACIL | 100038267 |
| 20210375 | 20078301 | 1.81 | 0 | Palliative (P) | 2018-01-13 | 2018-01-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101681560 |
| 20210376 | 20078302 | 1.66 | 49.4 | 03 | 2016-06-19 | 2016-06-20 | Capecitabine (21days) + Carboplatin | N | null | CISPLATIN + FLUOROURACIL | 100507832 |
| 20210377 | 20078303 | null | null | Curative (C) | null | 2018-09-19 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100546021 |
| 20210383 | 20078304 | 1.53 | 95 | Palliative (P) | 2018-06-29 | 2018-06-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101148420 |
| 20210386 | 20078305 | 0 | 0 | Palliative (P) | 2018-02-22 | 2019-04-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101788061 |
| 20210387 | 20078306 | 1.74 | 89.5 | Curative (C) | 2017-06-26 | 2017-07-10 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 101462166 |
| 20210389 | 20078307 | 1.74 | 79 | Palliative (P) | 2018-12-18 | 2018-12-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100292193 |
| 20210390 | 20078308 | 1.64 | 584 | Palliative (P) | 2019-12-01 | 2019-12-10 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100693254 |
| 20210391 | 20078309 | 1.7 | 81.1 | null | 2018-04-19 | 2018-05-23 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100173820 |
| 20210396 | 20078310 | 1.66 | 82 | Neo-adjuvant (N) | 2018-01-18 | 2018-02-01 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100773984 |
| 20210397 | 20078311 | 0 | 0 | Curative (C) | null | 2017-05-19 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101258197 |
| 20210398 | 20078312 | 0 | 0 | null | 2019-07-10 | 2019-07-19 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100148336 |
| 20210404 | 20078313 | 1.87 | 64.8 | Palliative (P) | null | 2016-05-16 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100647645 |
| 20210406 | 20078314 | 1.62 | 58 | Not known (9) | 2016-11-23 | 2016-11-23 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100154330 |
| 20210412 | 20078315 | 1.73 | 84 | Neo-adjuvant (N) | null | 2017-01-31 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101070803 |
| 20210424 | 20078316 | 0 | 0 | Palliative (P) | 2020-03-13 | 2020-04-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101163471 |
| 20210430 | 20078317 | 1.55 | 73.5 | Palliative (P) | 2016-06-08 | 2016-06-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100998502 |
| 20210431 | 20078318 | 1.67 | 132.9 | null | 2019-11-12 | 2019-11-14 | CAPECITABINE + CARBOPLATIN | 2 | null | CAPECITABINE + CARBOPLATIN | 100019435 |
| 20210433 | 20078319 | 1.66 | 42.1 | Neo-adjuvant (N) | 2018-03-14 | 2018-04-11 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101615958 |
| 20210443 | 20078320 | 1.54 | 72.5 | Neo-adjuvant (N) | 2017-11-24 | 2017-12-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101463823 |
| 20210445 | 20078321 | null | null | Palliative (P) | 2018-08-09 | 2018-08-11 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101277990 |
| 20210448 | 20078322 | 1.63 | 54.2 | null | 2018-08-24 | 2018-09-13 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 101544517 |
| 20210455 | 20078323 | 1.72 | null | Palliative (P) | 2020-01-03 | 2020-01-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100159446 |
| 20210456 | 20078324 | 1.7 | 78.6 | Curative (C) | 2019-03-27 | 2019-03-27 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101404084 |
| 20210463 | 20078325 | 1.74 | 127.3 | Curative (C) | 2019-10-19 | 2019-11-01 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101182649 |
| 20210466 | 20078326 | 1.67 | 71.6 | Palliative (P) | 2018-11-27 | 2018-12-09 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101622541 |
| 20210474 | 20078327 | 1.67 | 54.9 | 03 | 2016-05-26 | 2016-05-28 | CAPECITABINE + CARBOPLATIN | 02 | null | TRIAL UNSPECIFIED | 100268827 |
| 20210476 | 20078328 | 1.52 | 74.6 | Palliative (P) | 2017-03-20 | 2017-04-03 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101767458 |
| 20210478 | 20078329 | 1.79 | 56.1 | null | 2017-04-25 | 2017-05-01 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100316944 |
| 20210491 | 20078330 | 1.66 | 55 | null | 2018-05-22 | 2018-06-10 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101225305 |
| 20210492 | 20078331 | 0 | 0 | Curative (C) | 2017-01-22 | 2017-01-29 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101074578 |